tailieunhanh - Response biomarkers: Re-envisioning the approach to tailoring drug therapy for cancer

The rapidly expanding arsenal of chemotherapeutic agents approved in the past 5 years represents significant progress in the field. However, this poses a challenge for oncologists to choose which drug or combination of drugs is best for any individual. Because only a fraction of patients respond to any drug, efforts have been made to devise strategies to personalize care. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN